«Heyl Japan K.K.

Below is an extended Heyl Japan K.K. news listing. Click here to return to the Heyl Japan K.K. main Biocorporate entry.

BioNews Results for Heyl Japan K.K.:
TEVA PHARMACEUTICAL INDUSTRIES LTD EPS Estimated At 2.71: Current Recommendation is Outperform Macro World Investor: Sep 26 2008 4:49PM Matching: japan k
Welborn Foundation taps Evansville Courier: Sep 26 2008 1:41PM Matching: japan k
Welborn Foundation taps Evansville Courier: Sep 26 2008 6:13AM Matching: japan k
Merck & Co., Inc. and Japan Tobacco Inc. Sign Licensing Agreement for Novel Osteoanabolic Drug Candidate to Tr MarketWatch: Sep 25 2008 7:11AM Matching: japan k
Merck & Co., Inc. and Japan Tobacco Inc. Sign Licensing Agreement for Novel Osteoanabolic Drug Candidate to Tr TradingMarkets: Sep 25 2008 7:15AM Matching: japan k
Merck & Co., Inc. and Japan Tobacco Inc. Sign Licensing Agreement for Novel Osteoanabolic Drug Candidate to Tr Pharma Live: Sep 25 2008 2:03PM Matching: japan k
Focus on the World Vitamins Market TMC Net: Sep 24 2008 2:10PM Matching: japan k
Diagnosis, Evaluation, and Treatment for Resistant Hypertension: An AHA Statement Review of Endocrinology: Sep 24 2008 9:06AM Matching: japan k
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference Business Wire via Yahoo!: Sep 24 2008 7:47AM Matching: japan k
GTC Biotherapeutics, Inc. Q2 2008 Earnings Call Transcript Yahoo!: Sep 23 2008 9:38PM Matching: japan k
EntreMed, Inc. Q2 2008 Earnings Call Transcript Seeking Alpha: Sep 23 2008 5:58PM Matching: japan k
EntreMed, Inc. Q2 2008 Earnings Call Transcript Yahoo!: Sep 23 2008 5:29PM Matching: japan k
Effective Chemoradiotherapy Method For Pancreatic Cancer Medical News Today: Sep 22 2008 11:41AM Matching: japan k
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer Business Wire via Yahoo!: Sep 19 2008 11:06AM Matching: japan k
Pneumatosis cystoids intestinalis after fluorouracil chemotherapy Genetic Engineering News: Sep 18 2008 7:15AM Matching: japan k

«Heyl Japan K.K.

This page contained an extended Heyl Japan K.K. news listing. Click here to return to the Heyl Japan K.K. main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.